JERSEY CITY, N.J., July 29, 2014 - Verisk Analytics, Inc. (Nasdaq:VRSK), a leading source of data and analytics about risk, today announced results for the fiscal quarter ended June 30, 2014.
Scott Stephenson, president and chief executive officer, said, "Our second-quarter revenue growth was good, driven by very strong performance in our insurance units. The outlook for our financial business remains excellent, and we continue to expect mid teens growth for Verisk Health for the full year 2014. I am pleased with the efforts of all our people as they work to create the next generation of innovative solutions for our customers. We remain focused on driving long-term organic growth for Verisk and feel good about our asset mix, even as we continue to explore acquisitions that are a strong strategic fit."
Financial Highlights
· Total revenue from continuing operations increased 8.5% in second-quarter 2014 compared with second-quarter 2013. Decision Analytics revenue from continuing operations increased 10.8% in the quarter, while Risk Assessment revenue increased 5.0%.
· EBITDA from continuing operations increased 8.0% to $194.2 million for second-quarter 2014, with an EBITDA margin from continuing operations of 45.9%.
· Diluted GAAP earnings per share (diluted GAAP EPS) were $0.52 for second-quarter 2014. Diluted adjusted earnings per share from continuing operations (diluted adjusted EPS from continuing operations) were $0.57 for second-quarter 2014, an increase of 7.5% compared with the same period in 2013.
· Free cash flow year to date, normalized for the items discussed below, increased 4.0% to $228.1 million.
Table 1: Summary of Results
(in thousands, except per share amounts)
| Three Months Ended | Six Months Ended | ||||||||||||||||||||
| June 30, | June 30, | ||||||||||||||||||||
| 2014 | 2013 | Change | 2014 | 2013 | Change | ||||||||||||||||
| Revenues from continuing operations | $ | 423,554 | $ | 390,356 | 8.5 | % | $ | 833,197 | $ | 767,053 | 8.6 | % | |||||||||
| EBITDA from continuing operations | $ | 194,210 | $ | 179,856 | 8.0 | % | $ | 377,055 | $ | 356,450 | 5.8 | % | |||||||||
| Net income | $ | 88,099 | $ | 84,205 | 4.6 | % | $ | 203,657 | $ | 164,716 | 23.6 | % | |||||||||
| Adjusted net income from continuing operations | $ | 96,916 | $ | 92,178 | 5.1 | % | $ | 190,168 | $ | 182,195 | 4.4 | % | |||||||||
| Diluted GAAP EPS | $ | 0.52 | $ | 0.49 | 6.1 | % | $ | 1.20 | $ | 0.95 | 26.3 | % | |||||||||
| Diluted adjusted EPS from continuing operations | $ | 0.57 | $ | 0.53 | 7.5 | % | $ | 1.12 | $ | 1.06 | 5.7 | % | |||||||||
Revenue
Table 2: Decision Analytics Revenues by Category
(in thousands)
| Three Months Ended | Six Months Ended | ||||||||||||||||||||
| June 30, | June 30, | ||||||||||||||||||||
| 2014 | 2013 | Change | 2014 | 2013 | Change | ||||||||||||||||
| Insurance | $ | 152,831 | $ | 133,785 | 14.2 | % | $ | 294,261 | $ | 260,334 | 13.0 | % | |||||||||
| Financial services | 21,837 | 19,565 | 11.6 | % | 42,853 | 36,847 | 16.3 | % | |||||||||||||
| Healthcare | 65,092 | 61,087 | 6.6 | % | 128,988 | 120,136 | 7.4 | % | |||||||||||||
| Specialized markets | 21,842 | 21,660 | 0.8 | % | 42,830 | 42,864 | (0.1 | )% | |||||||||||||
| Total Decision Analytics | $ | 261,602 | $ | 236,097 | 10.8 | % | $ | 508,932 | $ | 460,181 | 10.6 | % | |||||||||
Within the Decision Analytics segment, revenue from continuing operations grew 10.8% in second-quarter 2014. In the quarter, Decision Analytics revenue from continuing operations represented approximately 61.8% of total revenue from continuing operations.
Within the insurance category, revenue growth was 14.2% for the second-quarter of 2014. The increase was driven by strong growth in catastrophe modeling and loss quantification solutions.
In the financial services category, revenue from continuing operations increased 11.6% in second-quarter 2014 based on continued strong demand for our solutions partially offset by lower project-related revenue.
In the healthcare category, revenue in the second quarter grew 6.6%, driven primarily by growth in revenue and quality intelligence solutions. Revenue growth reflected continued expansion of solutions sold to existing customers.
In the specialized markets category, revenue increased 0.8% in second-quarter 2014. Environmental health and safety solutions led the growth. This was offset by the expected continued cycling of a large government contract discussed previously.
Table 3: Risk Assessment Revenues by Category
(in thousands)
| Three Months Ended | Six Months Ended | ||||||||||||||||||||
| June 30, | June 30, | ||||||||||||||||||||
| 2014 | 2013 | Change | 2014 | 2013 | Change | ||||||||||||||||
| Industry-standard insurance programs | $ | 123,194 | $ | 117,289 | 5.0 | % | $ | 247,011 | $ | 233,739 | 5.7 | % | |||||||||
| Property-specific rating and underwriting information | 38,758 | 36,970 | 4.8 | % | 77,254 | 73,133 | 5.6 | % | |||||||||||||
| Total Risk Assessment | $ | 161,952 | $ | 154,259 | 5.0 | % | $ | 324,265 | $ | 306,872 | 5.7 | % | |||||||||
Within the Risk Assessment segment, revenue grew 5.0% in the quarter.
Revenue growth in industry-standard insurance programs was 5.0%, resulting primarily from the annual effect of growth in 2014 invoices effective from January 1 as well as growth from new solutions.
Property-specific rating and underwriting information revenue grew 4.8% in the second quarter. Growth was due to new sales resulting in higher committed volumes.
Cost of Revenue
Cost of revenue from continuing operations increased 13.1% in second-quarter 2014 compared with second-quarter 2013. The year-over-year increase relates primarily to meeting customer demand in our healthcare business. Investments in people, data, and technology, in support of the growth of the business, also contributed to the increase. For second-quarter 2014, cost of revenue from continuing operations increased 15.4% for Decision Analytics and 8.2% for Risk Assessment.
Selling, General, and Administrative
Selling, general, and administrative expense, or SG&A, from continuing operations decreased 1.9% in second-quarter 2014. In the quarter, SG&A from continuing operations increased 0.1% for Decision Analytics and decreased 5.9% for Risk Assessment.
EBITDA
Table 4: Segment EBITDA
(in thousands)
| Three Months Ended | Six Months Ended | ||||||||||||||||||||
| June 30, | June 30, | ||||||||||||||||||||
| 2014 | 2013 | Change | 2014 | 2013 | Change | ||||||||||||||||
| Decision Analytics | $ | 102,954 | $ | 93,523 | 10.1 | % | $ | 192,474 | $ | 184,042 | 4.6 | % | |||||||||
| EBITDA margin from continuing operations | 39.4 | % | 39.6 | % | 37.8 | % | 40.0 | % | |||||||||||||
| Risk Assessment | $ | 91,256 | $ | 86,333 | 5.7 | % | $ | 184,581 | $ | 172,408 | 7.1 | % | |||||||||
| EBITDA margin from continuing operations | 56.3 | % | 56.0 | % | 56.9 | % | 56.2 | % | |||||||||||||
| Total EBITDA from continuing operations | $ | 194,210 | $ | 179,856 | 8.0 | % | $ | 377,055 | $ | 356,450 | 5.8 | % | |||||||||
| EBITDA margin from continuing operations | 45.9 | % | 46.1 | % | 45.3 | % | 46.5 | % | |||||||||||||
Decision Analytics EBITDA from continuing operations increased 10.1% in second-quarter 2014, and Risk Assessment EBITDA grew 5.7% compared with the same period in the previous year.
The second-quarter 2014 EBITDA margin from continuing operations for Decision Analytics decreased to 39.4% from 39.6% in second-quarter 2013. The decline was the result of increased costs in our healthcare business partially offset by the previously discussed revenue growth in the segment.
The second-quarter 2014 EBITDA margin in Risk Assessment increased to 56.3% from 56.0% in second-quarter 2013 as a result of the previously discussed revenue growth, good expense management, and lower pension costs.
Net Income and Adjusted Net Income
Net income increased 4.6% in second-quarter 2014, primarily driven by the revenue growth discussed above. Adjusted net income from continuing operations grew 5.1% for second-quarter 2014.
Cash Flow
For the six-month period ended June 30, 2014, free cash flow, defined as cash provided by operating activities less capital expenditures, adjusted for the timing of excess tax benefits from exercised stock options in first-quarter 2013 and the sale of our mortgage services business, grew 4.0% compared with the prior-year period to $228.1 million and represented 60.5% of EBITDA from continuing operations in the first six months of 2014.
For the six-month period ended June 30, 2014, net cash provided by operating activities was $286.8 million, an increase of $40.1 million, or 16.3%, compared with the same period in 2013. Cash provided by operations as reported was affected by the timing of excess tax benefits from exercised stock options in first-quarter 2013 and $17.1 million in 2014 related to adjustments due to the sale of our mortgage services business. Adjusted for those items, growth for the quarter was 7.5%.
Capital expenditures were $75.8 million in the six months ended June 30, 2014, an increase of $12.3 million over the same period in 2013. Capital expenditures were 9.0% of revenue for the six months ended June 30, 2014.
Share Repurchases
The company continued to balance internal investment and acquisition initiatives with share repurchases. In second-quarter 2014, the company repurchased shares for a total cost of $30.4 million at an average price of $59.54. At June 30, 2014, the company had $346.2 million remaining under its share repurchase authorization.
Conference Call
Verisk's management team will host a live audio webcast on Wednesday, July 30, 2014, at 8:30 a.m. Eastern time (5:30 a.m. Pacific time) to discuss the financial results and business highlights. All interested parties are invited to listen to the live event via webcast on the Verisk investor website at http://investor.verisk.com. The discussion is also available through dial-in number 1-877-755-3792 for U.S./Canada participants or 512-961-6560 for international participants.
A replay of the webcast will be available for 30 days on the Verisk investor website and also through the conference call number 1-855-859-2056 for U.S./Canada participants or 404-537-3406 for international participants using Conference ID # 70747434.
About Verisk Analytics
Verisk Analytics (Nasdaq:VRSK) is a leading provider of information about risk to professionals in insurance, healthcare, financial services, government, and risk management. Using advanced technologies to collect and analyze billions of records, Verisk Analytics draws on vast industry expertise and unique proprietary data sets to provide predictive analytics and decision support solutions in fraud prevention, actuarial science, insurance coverages, fire protection, catastrophe and weather risk, data management, and many other fields. In the United States and around the world, Verisk Analytics helps customers protect people, property, and financial assets. For more information, visit www.verisk.com.
Contact:
Investor Relations
Eva Huston
Senior Vice President, Treasurer, and Chief Knowledge Officer
Verisk Analytics, Inc.
201-469-2142
eva.huston@verisk.com
David Cohen
Director, Investor Relations and Business Analytics
Verisk Analytics, Inc.
201-469-2174
david.e.cohen@verisk.com
Media
Rich Tauberman
MWW Group
(for Verisk Analytics)
202-600-4546
rtauberman@mww.com
Forward-Looking Statements
This release contains forward-looking statements. These statements relate to future events or to future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "target," "seek," "anticipate," "believe," "estimate," "predict," "potential," or "continue" or the negative of these terms or other comparable terminology. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and other factors that are, in some cases, beyond our control and that could materially affect actual results, levels of activity, performance, or achievements.
Other factors that could materially affect actual results, levels of activity, performance, or achievements can be found in Verisk's quarterly reports on Form 10-Q, annual reports on Form 10-K, and current reports on Form 8-K filed with the Securities and Exchange Commission. If any of these risks or uncertainties materialize or if our underlying assumptions prove to be incorrect, actual results may vary significantly from what we projected. Any forward-looking statement in this release reflects our current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to our operations, results of operations, growth strategy, and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, whether as a result of new information, future events, or otherwise.
Notes Regarding the Use of Non-GAAP Financial Measures
The company has provided certain non-GAAP financial information as supplemental information regarding its operating results. These measures are not in accordance with, or an alternative for, U.S. GAAP and may be different from non-GAAP measures reported by other companies. The company believes that its presentation of non-GAAP measures, such as EBITDA, EBITDA margin, adjusted net income, and adjusted EPS, provides useful information to management and investors regarding certain financial and business trends relating to its financial condition and results of operations. In addition, the company's management uses these measures for reviewing the financial results of the company and for budgeting and planning purposes.
Table 5: EBITDA Reconciliation
(in thousands)
| Three Months Ended | Six Months Ended | ||||||||||||||||||||
| June 30, | June 30, | ||||||||||||||||||||
| 2014 | 2013 | Change | 2014 | 2013 | Change | ||||||||||||||||
| Net income | $ | 88,099 | $ | 84,205 | 4.6 | % | $ | 203,657 | $ | 164,716 | 4.7 | % | |||||||||
| Depreciation and amortization of fixed and intangible assets | 34,944 | 32,872 | 6.3 | % | 68,937 | 64,087 | 7.6 | % | |||||||||||||
| Interest expense | 17,459 | 19,704 | (11.4 | )% | 34,898 | 39,794 | (12.3 | )% | |||||||||||||
| Provision for income taxes | 53,708 | 45,680 | 17.6 | % | 100,680 | 91,524 | 10.0 | % | |||||||||||||
| less: Discontinued operations, net of tax | - | (2,605 | ) | (100.0 | )% | (31,117 | ) | (3,671 | ) | 747.6 | % | ||||||||||
| EBITDA from continuing operations | $ | 194,210 | $ | 179,856 | 8.0 | % | $ | 377,055 | $ | 356,450 | 5.8 | % | |||||||||
EBITDA is a financial measure that management uses to evaluate the performance of our segments. In all periods shown here and going forward, the company defines "EBITDA" as net income before interest expense, income taxes, and depreciation and amortization of fixed and intangible assets. In previous periods, this measure also excluded investment income and realized gain on securities, net.
Although securities analysts, lenders, and others frequently use EBITDA in their evaluation of companies, EBITDA has limitations as an analytical tool and should not be considered in isolation or as a substitute for an analysis of our statement of cash flow reported under U.S. GAAP. Management uses EBITDA in conjunction with traditional U.S. GAAP operating performance measures as part of its overall assessment of company performance. Some of these limitations are as follows:
· EBITDA does not reflect our cash expenditures or future requirements for capital expenditures or contractual commitments.
· EBITDA does not reflect changes in, or cash requirement for, our working capital needs.
· Although depreciation and amortization are noncash charges, the assets being depreciated and amortized often will have to be replaced in the future, and EBITDA does not reflect any cash requirements for such replacements.
· Other companies in our industry may calculate EBITDA differently than we do, limiting the usefulness of their calculations as comparative measures.
Table 6: Net Income and Adjusted Net Income from Continuing Operations
(in thousands, except per share amounts)
| Three Months Ended | Six Months Ended | ||||||||||||||||||||
| June 30, | June 30, | ||||||||||||||||||||
| 2014 | 2013 | Change | 2014 | 2013 | Change | ||||||||||||||||
| Net income | $ | 88,099 | $ | 84,205 | 4.6 | % | $ | 203,657 | $ | 164,716 | 23.6 | % | |||||||||
| plus: Amortization of intangible assets | 14,221 | 17,061 | 28,433 | 34,113 | |||||||||||||||||
| less: Income tax effect on amortization of intangible assets | (5,404 | ) | (6,483 | ) | (10,805 | ) | (12,963 | ) | |||||||||||||
| less: Discontinued operations, net of tax | - | (2,605 | ) | (31,117 | ) | (3,671 | ) | ||||||||||||||
| Adjusted net income from continuing operations | $ | 96,916 | $ | 92,178 | 5.1 | % | $ | 190,168 | $ | 182,195 | 4.4 | % | |||||||||
| Basic adjusted EPS from continuing operations | $ | 0.58 | $ | 0.55 | 5.5 | % | $ | 1.14 | $ | 1.08 | 5.6 | % | |||||||||
| Diluted adjusted EPS from continuing operations | $ | 0.57 | $ | 0.53 | 7.5 | % | $ | 1.12 | $ | 1.06 | 5.7 | % | |||||||||
| Weighted average shares outstanding (in millions) | |||||||||||||||||||||
| Basic | 166.3 | 168.1 | 166.7 | 168.1 | |||||||||||||||||
| Diluted | 169.5 | 172.5 | 170.0 | 172.6 | |||||||||||||||||
Attached Financial Statements
Please refer to the full Form 10-Q filing for the complete financial statements and related notes.
VERISK ANALYTICS, INC.
CONSOLIDATED BALANCE SHEETS
As of June 30, 2014 (Unaudited) and December 31, 2013
| 2014 | 2013 | ||||||
| (unaudited) | |||||||
| (In thousands, except for share and per share data) | |||||||
| ASSETS | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 419,448 | $ | 165,801 | |||
| Available-for-sale securities | 3,837 | 3,911 | |||||
| Accounts receivable, net of allowance for doubtful accounts of $5,037 and $4,415, respectively | 177,973 | 158,547 | |||||
| Prepaid expenses | 37,183 | 25,657 | |||||
| Deferred income taxes, net | 5,076 | 5,077 | |||||
| Income taxes receivable | 28,500 | 67,346 | |||||
| Other current assets | 32,546 | 34,681 | |||||
| Current assets held-for-sale | - | 13,825 | |||||
| Total current assets | 704,563 | 474,845 | |||||
| Noncurrent assets: | |||||||
| Fixed assets, net | 272,875 | 233,373 | |||||
| Intangible assets, net | 420,747 | 447,618 | |||||
| Goodwill | 1,184,374 | 1,181,681 | |||||
| Pension assets | 68,659 | 60,955 | |||||
| Other assets | 24,059 | 20,034 | |||||
| Noncurrent assets held-for-sale | - | 85,945 | |||||
| Total assets | $ | 2,675,277 | $ | 2,504,451 | |||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
| Current liabilities: | |||||||
| Accounts payable and accrued liabilities | $ | 157,350 | $ | 188,264 | |||
| Short-term debt and current portion of long-term debt | 139,781 | 4,448 | |||||
| Pension and postretirement benefits, current | 2,437 | 2,437 | |||||
| Fees received in advance | 309,175 | 226,581 | |||||
| Current liabilities held-for-sale | - | 9,449 | |||||
| Total current liabilities | 608,743 | 431,179 | |||||
| Noncurrent liabilities: | |||||||
| Long-term debt | 1,135,645 | 1,271,439 | |||||
| Pension benefits | 13,024 | 13,007 | |||||
| Postretirement benefits | 3,140 | 2,061 | |||||
| Deferred income taxes, net | 194,523 | 198,604 | |||||
| Other liabilities | 43,917 | 36,043 | |||||
| Noncurrent liabilities held-for-sale | - | 4,529 | |||||
| Total liabilities | 1,998,992 | 1,956,862 | |||||
| Commitments and contingencies | |||||||
| Stockholders' equity: | |||||||
| Class A common stock, $.001 par value; 1,200,000,000 shares authorized; 544,003,038 shares issued and 166,364,452 and 167,457,927 outstanding, respectively | 137 | 137 | |||||
| Unearned KSOP contributions | (230 | ) | (306 | ) | |||
| Additional paid-in capital | 1,240,862 | 1,202,106 | |||||
| Treasury stock, at cost, 377,638,586 and 376,545,111 shares, respectively | (1,979,871 | ) | (1,864,967 | ) | |||
| Retained earnings | 1,457,764 | 1,254,107 | |||||
| Accumulated other comprehensive losses | (42,377 | ) | (43,488 | ) | |||
| Total stockholders' equity | 676,285 | 547,589 | |||||
| Total liabilities and stockholders' equity | $ | 2,675,277 | $ | 2,504,451 | |||
VERISK ANALYTICS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
For the Three and Six Months Ended June 30, 2014 and 2013
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
| 2014 | 2013 | 2014 | 2013 | ||||||||||||
| (In thousands, except for share and per share data) | |||||||||||||||
| Revenues | $ | 423,554 | $ | 390,356 | $ | 833,197 | $ | 767,053 | |||||||
| Expenses: | |||||||||||||||
| Cost of revenues (exclusive of items shown separately below) | 172,470 | 152,429 | 342,143 | 296,061 | |||||||||||
| Selling, general and administrative | 57,074 | 58,198 | 114,208 | 114,520 | |||||||||||
| Depreciation and amortization of fixed assets | 20,723 | 15,811 | 40,504 | 29,974 | |||||||||||
| Amortization of intangible assets | 14,221 | 17,061 | 28,433 | 34,113 | |||||||||||
| Total expenses | 264,488 | 243,499 | 525,288 | 474,668 | |||||||||||
| Operating income | 159,066 | 146,857 | 307,909 | 292,385 | |||||||||||
| Other income (expense): | |||||||||||||||
| Investment income | 74 | 34 | 94 | 78 | |||||||||||
| Realized gain (loss) on available-for-sale securities, net | 126 | 93 | 115 | (100 | ) | ||||||||||
| Interest expense | (17,459 | ) | (19,704 | ) | (34,898 | ) | (39,794 | ) | |||||||
| Total other expense, net | (17,259 | ) | (19,577 | ) | (34,689 | ) | (39,816 | ) | |||||||
| Income before income taxes | 141,807 | 127,280 | 273,220 | 252,569 | |||||||||||
| Provision for income taxes | (53,708 | ) | (45,680 | ) | (100,680 | ) | (91,524 | ) | |||||||
| Income from continuing operations | 88,099 | 81,600 | 172,540 | 161,045 | |||||||||||
| Income from discontinued operations, net of tax of $0 and $2,042, and $23,365 and $2,877, for the three and six months ended, June 30, 2014 and June 30, 2013, respectively | - | 2,605 | 31,117 | 3,671 | |||||||||||
| Net income | $ | 88,099 | $ | 84,205 | $ | 203,657 | $ | 164,716 | |||||||
| Basic net income per share: | |||||||||||||||
| Income from continuing operations | $ | 0.53 | $ | 0.48 | $ | 1.03 | $ | 0.96 | |||||||
| Income from discontinued operations | - | 0.02 | 0.19 | 0.02 | |||||||||||
| Basic net income per share | $ | 0.53 | $ | 0.50 | $ | 1.22 | $ | 0.98 | |||||||
| Diluted net income per share: | |||||||||||||||
| Income from continuing operations | $ | 0.52 | $ | 0.47 | $ | 1.02 | $ | 0.93 | |||||||
| Income from discontinued operations | - | 0.02 | 0.18 | 0.02 | |||||||||||
| Diluted net income per share | $ | 0.52 | $ | 0.49 | $ | 1.20 | $ | 0.95 | |||||||
| Weighted average shares outstanding: | |||||||||||||||
| Basic | 166,343,630 | 168,147,069 | 166,662,806 | 168,112,829 | |||||||||||
| Diluted | 169,503,664 | 172,467,688 | 169,962,577 | 172,614,164 | |||||||||||
VERISK ANALYTICS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
For the Six Months Ended June 30, 2014 and 2013
| 2014 | 2013 | ||||||
| (In thousands) | |||||||
| Cash flows from operating activities: | |||||||
| Net income | $ | 203,657 | $ | 164,716 | |||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
| Depreciation and amortization of fixed assets | 41,499 | 32,025 | |||||
| Amortization of intangible assets | 28,544 | 34,403 | |||||
| Amortization of debt issuance costs and original issue discount | 1,322 | 1,368 | |||||
| Allowance for doubtful accounts | 347 | 633 | |||||
| KSOP compensation expense | 7,703 | 7,357 | |||||
| Stock based compensation | 11,057 | 10,955 | |||||
| Gain on sale of discontinued operations | (65,410 | ) | - | ||||
| Realized (gain) loss on available-for-sale securities, net | (115 | ) | 100 | ||||
| Deferred income taxes | (3,519 | ) | 1,007 | ||||
| Loss on disposal of fixed assets | 735 | 428 | |||||
| Excess tax benefits from exercised stock options and restricted stock awards | (6,094 | ) | (63,934 | ) | |||
| Other operating activities, net | - | 28 | |||||
| Changes in assets and liabilities, net of effects from acquisitions: | |||||||
| Accounts receivable | (12,186 | ) | (8,752 | ) | |||
| Prepaid expenses and other assets | (13,593 | ) | (1,696 | ) | |||
| Income taxes | 44,808 | 24,171 | |||||
| Accounts payable and accrued liabilities | (26,674 | ) | (12,833 | ) | |||
| Fees received in advance | 81,666 | 86,866 | |||||
| Pension and postretirement benefits | (6,064 | ) | (4,099 | ) | |||
| Other liabilities | (848 | ) | (26,052 | ) | |||
| Net cash provided by operating activities | 286,835 | 246,691 | |||||
| Cash flows from investing activities: | |||||||
| Acquisitions | (4,001 | ) | (983 | ) | |||
| Purchase of non-controlling interest in non-public companies | (5,000 | ) | - | ||||
| Proceeds from sale of discontinued operations | 155,000 | - | |||||
| Proceeds from release of acquisition related escrows | - | 192 | |||||
| Purchases of fixed assets | (75,764 | ) | (63,505 | ) | |||
| Purchases of available-for-sale securities | (32 | ) | (4,967 | ) | |||
| Proceeds from sales and maturities of available-for-sale securities | 281 | 5,826 | |||||
| Other investing activities, net | - | 439 | |||||
| Net cash provided by (used in) investing activities | 70,484 | (62,998 | ) | ||||
| Cash flows from financing activities: | |||||||
| Repayment of current portion of long-term debt | - | (45,000 | ) | ||||
| Repayment of short-term debt, net | - | (10,000 | ) | ||||
| Repurchases of Class A common stock | (122,120 | ) | (135,595 | ) | |||
| Excess tax benefits from exercised stock options and restricted stock awards | 6,094 | 63,934 | |||||
| Proceeds from stock options exercised | 14,923 | 30,528 | |||||
| Net share settlement of restricted stock awards | (1,234 | ) | - | ||||
| Other financing activities, net | (2,095 | ) | (4,111 | ) | |||
| Net cash used in financing activities | (104,432 | ) | (100,244 | ) | |||
| Effect of exchange rate changes | 760 | (681 | ) | ||||
| Increase in cash and cash equivalents | 253,647 | 82,768 | |||||
| Cash and cash equivalents, beginning of period | 165,801 | 89,819 | |||||
| Cash and cash equivalents, end of period | $ | 419,448 | $ | 172,587 | |||
| Supplemental disclosures: | |||||||
| Taxes paid | $ | 82,624 | $ | 71,029 | |||
| Interest paid | $ | 34,002 | $ | 39,029 | |||
| Noncash investing and financing activities: | |||||||
| Repurchases of Class A common stock included in accounts payable and accrued liabilities | $ | - | $ | 3,550 | |||
| Deferred tax asset established on date of acquisition | $ | - | $ | 343 | |||
| Tenant improvement included in other liabilities | $ | 8,859 | $ | - | |||
| Capital lease obligations | $ | 1,274 | $ | 2,106 | |||
| Capital expenditures included in accounts payable and accrued liabilities | $ | 1,247 | $ | 3,426 | |||